Skip to main content
NSPR
NASDAQ Industrial Applications And Services

InspireMD CEO Discloses 5.18% Beneficial Ownership Stake

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$1.25
Mkt Cap
$58.616M
52W Low
$1.19
52W High
$2.932
52W Position info
5.0% above low
Off High info
57% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

NSPR is trading near its 52-week low of $1.19 (5.0% above the low).

Summary

InspireMD's CEO, Marvin Slosman, has disclosed a 5.18% beneficial ownership stake in the company, primarily accumulated through equity compensation awards.


Key Events · Ownership and Investor Activity · NSPR

  • CEO's Significant Stake Disclosed

    Marvin Slosman, CEO and Board Member, reported beneficial ownership of 2,556,760 shares, representing 5.18% of InspireMD's common stock.

  • Ownership Primarily from Equity Awards

    The majority of the CEO's stake was acquired through equity compensation awards, with a minor personal purchase of $24,998.60 in July 2025.

  • No Immediate Plans for Control Change

    The filing indicates no present plans to engage in actions that would change or influence the control of the company, though the CEO reserves the right to review his position.

  • Context of Financial Challenges

    This disclosure comes as InspireMD faces a 'going concern' warning and is actively pursuing capital raises, highlighting the CEO's significant vested interest in the company's future.


Analysis · NSPR · Industrial Applications And Services

This Schedule 13D filing reveals that CEO Marvin Slosman holds a significant 5.18% beneficial ownership in InspireMD, largely derived from equity compensation. While the filing states no immediate plans to influence corporate control, this substantial insider stake demonstrates strong alignment with shareholder interests, particularly as the company navigates a "going concern" warning and actively seeks to raise capital through an ATM program and a proposed increase in authorized shares. The CEO's vested interest could be a stabilizing factor during these challenging times.

At the time of this filing, NSPR was trading at $1.25 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $58.6M. The 52-week trading range was $1.19 to $2.93. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NSPR - Latest Insights

NSPR
Jul 29, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.6701
Real-time Price: $0.7222 info
Change: +$0.0521 (+8%) info
Market Cap: $33.827M info
NSPR
Jul 23, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.6949
Real-time Price: $0.7222 info
Change: +$0.0273 (+4%) info
Market Cap: $33.827M info
NSPR
Jul 02, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.699
Real-time Price: $0.7222 info
Change: +$0.0232 (+3%) info
Market Cap: $33.827M info
NSPR
Jun 11, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $0.8599
Real-time Price: $0.7222 info
Change: -$0.1377 (-16%) info
Market Cap: $33.827M info
NSPR
Jun 03, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.9601
Real-time Price: $0.7222 info
Change: -$0.2379 (-25%) info
Market Cap: $33.827M info